导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -12.43% | 867/1050 |
| 近一周 | -2.10% | 451/1104 |
| 近一月 | -4.12% | 515/1102 |
| 近一季 | -1.21% | 296/1092 |
| 近半年 | -10.31% | 770/1070 |
| 近一年 | -16.43% | 837/1018 |
| 近两年 | -5.68% | 906/926 |
| 近三年 | -24.40% | 791/834 |
| 成立以来 | 101.70% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.27% 733/1070 |
-13.62% 992/1101 |
- - |
- - |
| 2025 | -6.04% 949/1065 |
-4.89% 984/1014 |
1.50% 551/1038 |
-2.45% 1020/1050 |
-0.24% 468/1065 |
| 2024 | -7.41% 736/1011 |
-3.68% 513/960 |
-1.58% 412/983 |
5.47% 867/991 |
-7.40% 796/1011 |
| 2023 | -1.05% 117/952 |
16.12% 46/880 |
-1.50% 265/895 |
-10.03% 588/915 |
-3.85% 394/952 |
| 2022 | 4.28% 9/867 |
-3.95% 21/773 |
-0.50% 704/806 |
-11.62% 359/845 |
23.45% 6/867 |
| 2021 | 36.74% 41/740 |
-0.58% 173/580 |
17.37% 199/659 |
-4.39% 328/704 |
22.56% 4/740 |
| 2020 | 15.24% 393/554 |
-1.58% 203/419 |
18.28% 312/466 |
2.43% 394/517 |
-3.35% 506/554 |
| 2019 | 36.46% 248/410 |
27.45% 659/3053 |
2.85% 317/3201 |
0.10% 328/390 |
3.99% 362/410 |
| 2018 | - - |
- - |
-0.73% 897/2983 |
7.69% 17/2970 |
0.11% 447/2975 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 前海开源中药股票A VS. 东吴新产业精选股票A(580008) |